Celsion Corp (NASDAQ:CLSN)

2.89
Delayed Data
As of Feb 27
 -0.05 / -1.70%
Today’s Change
2.15
Today|||52-Week Range
4.03
+24.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$57.7M

Company Description

Celsion Corp. engages in the provision of oncology drug development services. It operates through developing and commercializing chemotherapeutic oncology drugs based on proprietary heat-activated liposomal technology. Its products include ThermoDox, TheraPlas, and TheraSilence. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Contact Information

Celsion Corp.
997 Lenox Drive
Lawrenceville New Jersey 08648
P:(609) 896-9100
Investor Relations:
(609) 482-2455

Employees

Shareholders

Mutual fund holders4.60%
Individual stakeholders14.16%
Other institutional11.70%

Top Executives

Michael H. TardugnoExecutive Chairman, President & CEO
Jeffrey Wayne ChurchCFO, Secretary & SVP-Investor Relations
Nicholas BorysChief Medical Officer & Vice President
Khursheed AnwerChief Scientific Officer
Raj PrabhakarExecutive Director-Strategic Planning

To view my watchlist

Not a member yet?

Sign up now for a free account